Figure 1From: MRI characterization of uterine fibroids may predict success of GnRH agonist therapy prior to magnetic resonance focused ultrasound (MRgFUS) treatmentSagittal T2-weighted image depicting a 471 cc heterogeneously hyperintense fibroid.Back to article page